Nrgene Technologies (Israel) Performance
| NRGN Stock | ILA 392.90 47.90 13.88% |
On a scale of 0 to 100, Nrgene Technologies holds a performance score of 13. The company secures a Beta (Market Risk) of -0.11, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Nrgene Technologies are expected to decrease at a much lower rate. During the bear market, Nrgene Technologies is likely to outperform the market. Please check Nrgene Technologies' downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Nrgene Technologies' current price movements will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nrgene Technologies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nrgene Technologies sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Nrgene |
Nrgene Technologies Relative Risk vs. Return Landscape
If you would invest 31,000 in Nrgene Technologies on August 28, 2024 and sell it today you would earn a total of 8,290 from holding Nrgene Technologies or generate 26.74% return on investment over 90 days. Nrgene Technologies is generating 0.5699% of daily returns and assumes 3.3676% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Nrgene, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nrgene Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nrgene Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nrgene Technologies, and traders can use it to determine the average amount a Nrgene Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1692
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NRGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Nrgene Technologies is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nrgene Technologies by adding it to a well-diversified portfolio.
Nrgene Technologies Fundamentals Growth
Nrgene Stock prices reflect investors' perceptions of the future prospects and financial health of Nrgene Technologies, and Nrgene Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nrgene Stock performance.
| Return On Equity | -0.44 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (2.00) % | |||
| Operating Margin | (1.94) % | |||
| Current Valuation | 28.77 M | |||
| Shares Outstanding | 12.52 M | |||
| Price To Book | 1.58 X | |||
| Price To Sales | 20.41 X | |||
| Revenue | 3.8 M | |||
| EBITDA | (7.25 M) | |||
| Cash And Equivalents | 1.48 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 5.08 M | |||
| Book Value Per Share | 1.15 X | |||
| Cash Flow From Operations | (1.42 M) | |||
| Earnings Per Share | (0.69) X | |||
About Nrgene Technologies Performance
By analyzing Nrgene Technologies' fundamental ratios, stakeholders can gain valuable insights into Nrgene Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nrgene Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nrgene Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Energin .R Technologies 2009 LTD., a genomic big data company, provides computational tools to seed and food companies worldwide. The company was founded in 2009 and is headquartered in Ness Ziona, Israel. ENERGIN R operates under SoftwareApplication classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.Things to note about Nrgene Technologies performance evaluation
Checking the ongoing alerts about Nrgene Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nrgene Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nrgene Technologies appears to be risky and price may revert if volatility continues | |
| Nrgene Technologies has accumulated 5.08 M in total debt. Nrgene Technologies has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nrgene Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Nrgene Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nrgene Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nrgene to invest in growth at high rates of return. When we think about Nrgene Technologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 3.8 M. Net Loss for the year was (3.15 M) with profit before overhead, payroll, taxes, and interest of 2.46 M. | |
| Nrgene Technologies has accumulated about 1.48 M in cash with (1.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Nrgene Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nrgene Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Nrgene Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nrgene Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nrgene Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nrgene Technologies' stock. These opinions can provide insight into Nrgene Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nrgene Stock analysis
When running Nrgene Technologies' price analysis, check to measure Nrgene Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nrgene Technologies is operating at the current time. Most of Nrgene Technologies' value examination focuses on studying past and present price action to predict the probability of Nrgene Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nrgene Technologies' price. Additionally, you may evaluate how the addition of Nrgene Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |